Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Medtech Insight

Generics Bulletin

US FDA's Generics Program Reaches 'Steady State' Milestone

Sep 07 2018

• By Derrick Gingery

FDAEntrance_1200x675

Related Content

Generic Review At US FDA: Record Month Completes Approval Volume Recovery

Aug 12 2018

Generics Office At US FDA Could Get New Director Before Uhl Departs

Jul 19 2018

GDUFA II Reviews Start Strong With High First-Cycle Approval Rate

Dec 04 2017

Generic User Fees Would Create 10-Month ANDA Review Time

May 02 2011

Generic Drug Review: US FDA Approves More ANDAs Than It Receives For First Time Since Early 2016

Mar 09 2017

GDUFA Success Story: FDA Exceeds Hiring Goals, Names OGD Director

Jan 15 2015

GDUFA Success Depends On Industry Changes As Much As Review Improvements, FDA Says

Nov 04 2013

Additional Topics

United States Generic Drugs Review Pathway Regulation FDA BioPharmaceutical

More from Generics

More from Products

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
Editorial Standards
Award-Winning Journalism
AdvertiseOpens in new window
Contact Us
Evaluate Home

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Generics Top 50 Ranking
Biosimilars
Generics
Value Added Medicines

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window